By Janine Rauscher | Director, Development Operations
As we approach another Melanoma Awareness Month, our collective commitment to discovery that will help end death and suffering due to melanoma remains unwavering. Over the past two decades, the Melanoma Research Alliance has proudly supported 17 groundbreaking treatments—but too many patients still need help.
At a time when critical medical research funding is being cut, MRA launched the SPF Initiative Save Protect Fund to address underfunded melanoma research and other urgent unmet needs. Since last May, MRA has raised a total of $581,361.28 dedicated directly to advancing melanoma research.
MRA’s leadership prevails as the largest nonprofit, non-governmental funder of melanoma research in the world, having proudly invested more than $175 million in over 500 melanoma research projects at 165 institutions. MRA continues to innovate to meet the evolving needs of scientists and researchers, and patients and caregivers. This year, in addition to funding $9.3 million in new research grants, MRA expanded our RARE Melanoma Registry recruiting over 600 patients (approximately one-third each with acral, mucosal, or non-acral cutaneous melanoma). Additionally, MRA launched our innovative Next Steps Program to award milestone-based funding to scientists and projects in need of support for the ‘next steps’ to accelerate discoveries from the lab bench to the clinic.
Links:
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
Support this important cause by creating a personalized fundraising page.
Start a Fundraiser
